|                                              |              | AZD1          | AZD2        |              |
| -------------------------------------------- | ------------ | ------------- | ----------- | ------------ |
|                                              |              | <<low dose>> | <<high dose>> | Control    |
| Statistic  Event [a]                         |              |N=xxx        | N=xxx         | N=xxx       |
|                                   |          |              |             |              |
| Any                                          | n (%)        |   x (x.x)     |   xx (xx.x) |   x (x.x)    |
| <<RECIST>> progression                       | n (%)        |   x (x.x)     |   xx (xx.x) |   x (x.x)    |
|    Target lesions [b]                        | n (%)        |   x (x.x)     |   xx (xx.x) |   x (x.x)    |
|    Non target lesions [b]                    | n (%)        |   x (x.x)     |   xx (xx.x) |   x (x.x)    |
|    New lesions [b]                           | n (%)        |   x (x.x)     |   xx (xx.x) |   x (x.x)    |
| Death without progression                    | n (%)        |   x (x.x)     |   xx (xx.x) |   x (x.x)    |
|                                              |              |               |             |              |
| Censored observations                        |              |               |
| Any                                          | n (%)        |   x (x.x)     |   xx (xx.x) |   x (x.x)    |
| Censored at Day 1                            | n (%)        |   x (x.x)     |   xx (xx.x) |   x (x.x)    |
| Censored <<RECIST>> progression or death [c] | n (%)        |   x (x.x)     |   xx (xx.x) |   x (x.x)    |
| Progression-free [d]                         | n (%)        |   x (x.x)     |   xx (xx.x) |   x (x.x)    |
| Prematurely censored                         | n (%)        |   x (x.x)     |   xx (xx.x) |   x (x.x)    |
| Progression-free at time of the analysis     | n (%)        |   x (x.x)     |   xx (xx.x) |   x (x.x)    |
| Early study discontinuation                  | n (%)        |   x (x.x)     |   xx (xx.x) |   x (x.x)    |
| Lost to follow-up                            | n (%)        |   x (x.x)     |   xx (xx.x) |   x (x.x)    |
| Withdrew consent                             | n (%)        |   x (x.x)     |   xx (xx.x) |   x (x.x)    |
| <<category>>                                 | n (%)        |   x (x.x)     |   xx (xx.x) |   x (x.x)    |
|                                              |              |               |             |              |
| Progression-free survival                    | P25          |      x.x      |      x.x    |      x.x     |
| (<<unit>>) [e] [f]                           | Median       |     xx.x      |     xx.x    |     xx.x     |
|                                              | <<x>>% CI    |   x.x, x.x    |    x.x, x.x |    x.x, x.x  |
|                                              | P75          |      x.x      |      x.x    |      x.x     |
| P<<x>>                                       |      x.x     |      x.x      |      x.x    |
|                                              |              |               |             |              |
| Comparison of treatment groups [g]           | Hazard ratio |      x.x      |      x.x    |              |
|                                              | <<x>>% CI    | x.x, x.x      | x.x, x.x    |              |
|                                              | <<x>>% CI    | x.x, x.x      | x.x, x.x    |              |
|                                              | p-value      |      0.xxx    |      0.xxx  |              |
|                                              |              |               |             |              |
|                                              |              |               |             |              |
| Progression-free survival rate [e]           |              |               |             |              |
| <<xx months>>                                | %            |     xx.x      |     xx.x    |      xx.x    |
|                                              | <<x>>% CI    | x.x, x.x      |   x.x, x.x  |     x.x, x.x |
|                                              | …            |               |             |              |
|                                              |              |               |             |              |
| <<xx months>>                                | %            |     xx.x      |     xx.x    |      xx.x    |
|                                              | <<x>>% CI    | x.x, x.x      |   x.x, x.x  |     x.x, x.x |
|                                              | …            |               |             |              |
|                                              |              |               |             |              |
|                                              |              |               |             |              |
|                                              |              |               |             |              |
| Missed two or more consecutive               | n (%)        |   x (x.x)     |   xx (xx.x) |   x (x.x)    |
|                                              |              |               |             |              |
| <<RECIST>> assessments                       |              |               |
| Duration between <<RECIST>> progression      | n            |      x        |      x      |      x       |
| and the last evaluable <<RECIST>>            | Min          |     xx.x      |     xx.x    |     xx.x     |
| assessment prior to progression (<<unit>>)   | Q1           |      x.x      |      x.x    |      x.x     |
|                                              | Median       |     xx.x      |     xx.x    |     xx.x     |
|                                              | Q3           |     xx.x      |     xx.x    |     xx.x     |
|                                              | Max          |     xx        |     xx      |     xx       |